北美眼部药物输送市场预测至 2028 年 - COVID-19 影响和区域技术分析（植入式眼部药物输送系统、颗粒药物输送系统、纳米颗粒药物输送系统等）、制剂类型（脂质体和纳米颗粒、解决方案）、乳剂、混悬剂和软膏）、疾病类型（青光眼、糖尿病视网膜病变、干眼综合症、黄斑变性、白内障、糖尿病黄斑水肿等）和最终用户（医院、眼科诊所和门诊手术中心）

市场介绍

北美眼部药物输送市场已细分为美国、加拿大和墨西哥。美国占据北美眼部药物输送市场的最大份额。在北美，美国在眼部给药市场中占有重要份额。美国市场的增长主要是由产品意识和眼部疾病患病率的增加推动的。此外，美国人口老龄化可能会增加眼部疾病的发病率，这最终将推动眼部给药产品在该国的采用。例如，根据 2019 年人口资料局的数据，到 2060 年，美国 65 岁及以上年龄组的人口数量预计将从 2018 年的 5200 万增加一倍，达到 9500 万左右，而且 65 岁及以上年龄组在人口中所占的比例也将增加一倍。总人口将从16%增加到23%。这些老年人口非常容易受到眼部疾病的影响。例如，根据美国眼科学会 2019 年的研究，预计到 2050 年，美国将有 732 万名 70-75 岁的人受到原发性开角型青光眼 (POAG) 的影响。

在新冠肺炎疫情中，自 2020 年 1 月 19 日危机以来，医疗机构在 2020 年第一季度和第二季度颁布了减少住院患者就诊的法令，以防止 COVID-19 的传播。根据 CDC 最近的研究，医疗急诊科 (ED) 就诊的数量在 COVID-19 早期期间下降了 42%。因此，医院和诊所每周进行的选择性眼科手术数量随着时间的推移而减少。根据《眼科时报》的一篇文章，美国等国家的选择性手术有所减少。前往检查机构就诊的患者数量减少了 15%。在 COVID-19 大流行期间，眼科失去了相当大一部分的患者数量；由于寻求青光眼和白内障手术治疗的患者数量减少，预计眼科诊所数量将减少 81%。

市场概况和动态

北美眼部给药市场预计将从 2021 年的 62.8654 亿美元增长到 2028 年的 106.2277 亿美元。预计从 2021 年开始，该市场将以 7.8% 的复合年增长率增长到 2028 年。眼部药物输送市场的几家参与者正在开发和推出创新产品。开发和推出新产品的策略有助于公司迎合广泛的客户群。例如，2020年6月，千住制药株式会社和大冢制药株式会社宣布推出新型复方滴眼液AILAMIDE复方眼用混悬液，用于治疗青光眼和高眼压症。同样，2019年10月，太阳药业在美国推出了用于治疗干眼症的眼药水Cequa。此外，2019年5月，Menicon Co., Ltd推出了Menicon Bloom近视控制管理系统。 Menicon Bloom Night 疗法包括夜间佩戴专门设计的反向几何角膜塑形隐形眼镜，采用超透氧的 Menicon Z 刚性材料制成，可保证理想的角膜氧合，实现舒适的隐形眼镜佩戴。此外，Oural Therapeutix 于 2019 年 1 月在美国推出了 0.4 mg Dextenza（地塞米松眼科插入物），用于治疗眼科手术后的眼部炎症和疼痛。 Dextenza 于 2018 年 11 月获得 FDA 批准，用于治疗眼科手术后眼部疼痛。此类新产品的开发和推出正在成为眼部药物输送市场的主要趋势。

主要细分市场

北美眼部药物输送市场根据技术、制剂类型、疾病类型、最终用户进行细分。按技术划分，2021年植入式眼部给药系统份额最高。按剂型划分，2021年溶液细分市场份额最高。按疾病类型划分，2021年白内障细分市场份额最高。终端用户医院细分市场在 2021 年占据最高份额。

主要来源和上市公司

一些主要的初级和准备本北美眼部药物输送市场报告时参考的二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有艾伯维公司（AbbVie Inc.）；博士健康公司；诺华公司； Clearside 生物医学公司；眼科治疗公司；恩维西亚治疗公司；阿利梅拉科学公司； EYEGATE PHARMACEUTICALS, INC.等等。

购买报告的理由

通过确定北美眼部药物输送市场的增长、规模、领先参与者和细分市场，节省和减少进行入门级研究的时间
突出关键业务优先事项，以帮助公司重新调整业务战略
主要发现和建议突出了北美眼部药物输送市场的重要进步行业趋势，从而使整个价值链的参与者能够开发有效的长期- 长期战略
利用发达市场和新兴市场的大幅增长来制定/修改业务扩张计划
深入审查北美市场趋势和前景以及眼科药物的驱动因素交付市场以及阻碍该市场的因素
通过了解支持客户产品、细分、定价和分销方面的商业利益的策略，加强决策过程

北美眼部给药市场细分

北美眼部药物输送市场 –按技术划分

植入式眼部药物输送系统
颗粒药物输送系统
纳米粒子给药系统
其他

< span>北美眼部给药市场 –按配方类型

溶液
软膏
悬浮液
乳液
脂质体和纳米粒子

< p>北美眼部药物输送市场 –按疾病类型

N北美眼部药物输送市场 –按最终用户

医院
眼科诊所
门诊手术中心

北美眼部药物输送市场 -按国家/地区

美国
加拿大
墨西哥

北美眼部药物输送市场 -提及的公司

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Ocular Drug Delivery Market – By Technology

1.3.2 North America Ocular Drug Delivery Market – By Formulation Type

1.3.3 North America Ocular Drug Delivery Market – By Disease Type

1.3.4 North America Ocular Drug Delivery Market – By End User

1.3.5 North America Ocular Drug Delivery Market – By Country

2. North America Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Ocular Drug Delivery – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. North America Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Elevating Prevalence of Eye Disorders

5.2 Market Restraints

5.2.1 Limitations Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Expansion Awareness About Vision Care

5.4 Future Trends

5.4.1 Thriving of Innovative Products

5.5 Impact analysis

6. North America Ocular Drug Delivery – Market Analysis

6.1 North America Ocular Drug Delivery Market Revenue Forecast and Analysis

7. North America Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 North America Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. North America Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 North America Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. North America Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 North America Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. North America Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. North America Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

11.1.1.1 US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1 US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2 US Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.3 US: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.4 US: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.5 US: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.1.2 Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1 Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2 Canada Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.3 Canada Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.4 Canada Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.5 Canada Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.1.3 Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1 Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2 Mexico Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.3 Mexico Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.4 Mexico Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.5 Mexico Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on North America Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Ocular Therapeutix, Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Alimera Sciences, Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Envisia Therapeutics

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Novartis AG

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 EYEGATE PHARMACEUTICALS, INC

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Clearside Biomedical, Inc.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. US Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 2. US Ocular Drug Delivery Market, by Formulation Type - Revenue and Forecast to 2028 (USD Million)

Table 3. US Ocular Drug Delivery Market, by Disease Type - Revenue and Forecast to 2028 (USD Million)

Table 4. US Ocular Drug Delivery Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Ocular Drug Delivery Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments Done By Companies

Table 14. Inorganic Developments Done by Companies

Table 15. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. North America Ocular Drug Delivery Market Segmentation

Figure 2. North America Ocular Drug Delivery Market Segmentation, By Country

Figure 3. North America Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America Ocular Drug Delivery Market, Industry Landscape

Figure 7. North America PEST Analysis

Figure 8. North America Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. North America Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. North America Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. North America Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. North America Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. North America: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (USD Million)

Figure 34. North America: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

Figure 35. US: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Canada: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Mexico: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Impact of COVID-19 Pandemic in North American Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America ocular drug delivery market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in North America ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample